Company

AMILI

Microbiome science company running a multi-ethnic Asian gut microbiome biobank and reference database, which it uses to interpret consumer and clinician-ordered stool tests. Commercial output is diagnostic rather than therapeutic: a gut microbiome test kit and an enhanced version, four targeted probiotic formulations (immune-metabolic, complete, cognitive, digestive), microbiome restoration therapy, and AMILI Optimise Plus, a metabolic health programme that pairs microbiome profiling with continuous glucose monitoring and nutritionist input. Distribution runs through a partner clinic network. Longevity relevance is indirect: it sits in the metabolic-health and personalised-nutrition layer, measuring and modifying a biomarker set (gut composition, glycaemic response) associated with cardiometabolic risk, not intervening in ageing biology directly. Efficacy claims for microbiome-guided nutrition remain contested in the literature; the company's own database size claims are self-reported and not independently verified here.

At a glance

Listing
Private, not listed
Category
Diagnostics
Headquarters
Singapore (89 Science Park Drive, #03-09, The Rutherford, Science Park 1)
Market cap
Not disclosed

Thesis

Why it is in this universe

Category
Diagnostics
Market
Singapore
Recent inflection
On 21 April 2026, Calbee launched its Body Granola personalised nutrition service in Singapore with AMILI supplying the gut microbiome testing component, extending AMILI from direct-to-consumer testing into a consumer packaged goods partnership (NutraIngredients, 22 April 2026).
Services
None recorded
People tracked
None on file

Market data

Listing and scale

MetricDetail
ExchangeUnlisted
TickerNone
Secondary listingNone
Market capNot disclosed
StatusPrivate
Editor's noteA listing or financing event is not a clinical result. variis grades evidence on the linked protocol, not the share price.

Get in touch

Contact

Address
Singapore (89 Science Park Drive, #03-09, The Rutherford, Science Park 1)
Phone
No public number published
Email
No public address published

Offering

What it sells today

No commercial services are recorded for this company yet.

Recent inflection

What moved lately

On 21 April 2026, Calbee launched its Body Granola personalised nutrition service in Singapore with AMILI supplying the gut microbiome testing component, extending AMILI from direct-to-consumer testing into a consumer packaged goods partnership (NutraIngredients, 22 April 2026).

Keep reading

Related coverage from the newsroom.

Suggest an updateJoin the community

Every entity profile on variis is sourced. Not investment advice.